Patent US6251079B1 successfully refreshed from Google Patents.
US6251079B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Transthoracic drug delivery device
Assignee: CR Bard Inc
•
Filing: 1998-09-30
•
Granted: 2001-06-26
•
Expires: 2018-09-30
Abstract
Abstract The present invention provides a transthoracic drug delivery device that utilizes pressure to determine the precise location of the distal tip of the delivery tube of the device to insure that therapeutic substances are ejected into the myocardium and not dissipated in unintended tissue locations. In one embodiment the drug delivery device comprises a pressure sensing tube mounted in parallel to a drug delivery tube wherein the tubes are staggered so that the pressure tube extends beyond the delivery tube. When the myocardium is penetrated by the tubes, advancement into the heart and penetration into the left ventricle by the pressure sensing tube results in a pressure increase that indicates to the physician that the drug delivery tube, by its placement relative to the pressure sensing tube is still in the myocardium and, thus, prepared to deliver the drug. In another embodiment, a steerable syringe is provided so that multiple sites in the myocardium can be treated with a therapeutic substance with only one penetration into the heart. Once the delivery tube of the syringe penetrates the left ventricle, its distal tip can be deflected back toward the endocardial surface and the tube withdrawn proximally to cause penetration of the tip into the myocardium. A pressure sensor mounted to the tube indicates, by a measured drop in pressure that the myocardium has been penetrated. The therapeutic substance is ejected into the myocardium and the device is then backed out of the tissue by advancing the syringe in a distal direction. The deflectable tip can be adjusted to a different deflection angle and the delivery tube rotated to make available a circular array of points that may be accessed by the syringe.
Inventors
- 👤 Richard A. Gambale
- 👤 Stephen J. Forcucci
- 👤 Richard T. Choh
- 👤 Robert Cafferata
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:26
CPC Classifications
A; A61; A61M; A61M25/00; A61M25/0067; A61M25/0068; A61M25/008; A61M25/0082; A61M25/0084; A61M25/01; A61M25/0105; A61M25/0133; A61M25/0147; A61B; A61B17/00; A61B17/00234; A61B2017/00238; A61B2017/00243; A61B2017/00247; A61B18/00; A61B2018/00315; A61B2018/00345; A61B2018/00351; A61B2018/00392; A61M2025/0001; A61M2025/0002; A61M2025/0003; A61M25/0021; A61M25/0023; A61M25/0026; A61M2025/0034; A61M2025/0036; A61M2025/0085; A61M2025/0086; A61M2210/00; A61M2210/10
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
68 words
A transthoracic drug delivery device comprising: a pressure sensing tube and a drug delivery tube joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue; wherein the pressure sensing tube extends distally beyond the drug delivery tube.
Claim 2
Dependent Claim
68 words
A transthoracic drug delivery device comprising: a pressure sensing tube and a drug delivery tube joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue; wherein the pressure sensing tube extends distally beyond the drug delivery tube.
Claim 3
Dependent Claim
31 words
A transthoracic drug delivery device as defined in claim 1 wherein the known distance between the ends of the staggered tubes is less than the thickness of a subject patient's myocardium.
Claim 4
Dependent Claim
79 words
A transthoracic drug delivery device comprising: a pressure sensing tube and a drug delivery tube joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue, and a pressure monitor joined to the pressure sensing tube and a source of a therapeutic substance joined to the drug delivery tube.
Claim 5
Dependent Claim
79 words
A transthoracic drug delivery device comprising: a pressure sensing tube and a drug delivery tube joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue, and a pressure monitor joined to the pressure sensing tube and a source of a therapeutic substance joined to the drug delivery tube.
Claim 6
Dependent Claim
58 words
A transthoracic drug delivery device comprising: a pressure sensing tube and a plurality of drug delivery tubes joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue.
Claim 7
Dependent Claim
58 words
A transthoracic drug delivery device comprising: a pressure sensing tube and a plurality of drug delivery tubes joined to the pressure sensing tube in a parallel relationship, but staggered so that one tube extends distally beyond the other by a known distance and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue.
Claim 8
Independent Claim
145 words
A method of delivering a therapeutic substance to the myocardium comprising: providing a delivery device comprised of a pressure sensing tube joined to at least one drug delivery tube maintained in parallel but staggered so that the pressure tube extends distally beyond the drug delivery tube by a known distance that is less than the thickness of the myocardium and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue; transthoracically accessing the heart; inserting the tubes into the heart; monitoring the pressure sensed by the tube while moving the device further into the heart; stopping advancement of the device into the heart when a dramatic pressure increase is noted indicating pressure sensing tube has entered the ventricle and the delivery tube id within the myocardium; ejecting a quantity of a therapeutic substance from the delivery tube into the myocardium.
Claim 9
Independent Claim
145 words
A method of delivering a therapeutic substance to the myocardium comprising: providing a delivery device comprised of a pressure sensing tube joined to at least one drug delivery tube maintained in parallel but staggered so that the pressure tube extends distally beyond the drug delivery tube by a known distance that is less than the thickness of the myocardium and at least the distally oriented tube has a sharpened distal tip configured to penetrate tissue; transthoracically accessing the heart; inserting the tubes into the heart; monitoring the pressure sensed by the tube while moving the device further into the heart; stopping advancement of the device into the heart when a dramatic pressure increase is noted indicating pressure sensing tube has entered the ventricle and the delivery tube id within the myocardium; ejecting a quantity of a therapeutic substance from the delivery tube into the myocardium.
References Cited (Backward Citations)
US3680544A
Cited
US3991750A
Cited
USRE31873F1
Cited
USRE31873E
Cited
US4217911A
Cited
US4461280A
Cited
US4451253A
Cited
US4551129A
Cited
US4774949A
Cited
EP0132387A2
Cited
US4718425A
Cited
US4700692A
Cited
US4894057A
Cited
US4808164A
Cited
US4920980A
Cited
US5487739A
Cited
US4901731A
Cited
EP0363661A1
Cited
US4917666A
Cited
WO1990006723A1
Cited
US5328470A
Cited
EP0490459A1
Cited
US5380316A
Cited
US5389096A
Cited
US5562613A
Cited
US5501664A
Cited
US5284138A
Cited
US5269326A
Cited
US5833645A
Cited
US5454374A
Cited
US5629008A
Cited
WO1994005265A1
Cited
US5429144A
Cited
US5409019A
Cited
US5287861A
Cited
US5656029A
Cited
US5452733A
Cited
US5682906A
Cited
US5562922A
Cited
WO1994027612A1
Cited
US5405376A
Cited
WO1995033511A1
Cited
US5514130A
Cited
US5830502A
Cited
EP0717969A2
Cited
WO1996020698A2
Cited
US5614206A
Cited
US5666970A
Cited
US5744515A
Cited
WO1996039830A1
Cited
US5840059A
Cited
WO1996040368A1
Cited
WO1997016169A1
Cited
US5701905A
Cited
US5769843A
Cited
US5810836A
Cited
WO1997038730A2
Cited
WO1997042910A1
Cited
WO1997045105A1
Cited
WO1997047253A1
Cited
US5662124A
Cited
WO1998005307A1
Cited
US5755682A
Cited
US5655548A
Cited
EP0830873A2
Cited
WO1998016644A1
Cited
US5756127A
Cited
DE29619029U1
Cited
US5971993A
Cited
WO1998023228A1
Cited
EP0853921A2
Cited
WO1998029148A1
Cited
WO1998032859A1
Cited
WO1998046115A2
Cited
WO1999021510A1
Cited
US5980548A
Cited
US6045565A
Cited
WO1999038459A2
Cited
WO1999053863A1
Cited
EP0953320A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2004-06-25 | 2004-12-25 | 2005-06-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2008-06-25 | 2008-12-25 | 2009-06-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2012-06-25 | 2012-12-25 | 2013-06-26 | $7700.00 | Window Closed / Lapsed |